Susquehanna International Group’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,587,300
| Closed | -$135M | – | 12103 |
|
|
2020
Q3 | $135M | Sell |
1,587,300
-56,500
| -3% | -$2.86M | 0.03% | 465 |
|
|
2020
Q2 | $58.3M | Buy |
1,643,800
+1,074,200
| +189% | +$31.4M | 0.01% | 747 |
|
|
2020
Q1 | $7.68M | Sell |
569,600
-734,700
| -56% | -$12.4M | ﹤0.01% | 2060 |
|
|
2019
Q4 | $27.6M | Sell |
1,304,300
-432,100
| -25% | -$7.62M | 0.01% | 1166 |
|
|
2019
Q3 | $23M | Buy |
1,736,400
+324,000
| +23% | +$4.76M | 0.01% | 1228 |
|
|
2019
Q2 | $19.6M | Buy |
1,412,400
+198,900
| +16% | +$2.99M | 0.01% | 1296 |
|
|
2019
Q1 | $23.3M | Sell |
1,213,500
-244,700
| -17% | -$3.94M | 0.01% | 1079 |
|
|
2018
Q4 | $20.8M | Buy |
1,458,200
+368,400
| +34% | +$7.31M | 0.01% | 1046 |
|
|
2018
Q3 | $22.7M | Buy |
1,089,800
+162,600
| +18% | +$3.85M | 0.01% | 1228 |
|
|
2018
Q2 | $21.9M | Buy |
927,200
+49,000
| +6% | +$985K | 0.01% | 1221 |
|
|
2018
Q1 | $12.8M | Sell |
878,200
-1,149,400
| -57% | -$18.8M | ﹤0.01% | 1579 |
|
|
2017
Q4 | $32.8M | Buy |
2,027,600
+543,100
| +37% | +$6.41M | 0.01% | 920 |
|
|
2017
Q3 | $20.8M | Buy |
1,484,500
+656,100
| +79% | +$6.54M | 0.01% | 1199 |
|
|
2017
Q2 | $7.32M | Buy |
828,400
+107,300
| +15% | +$753K | ﹤0.01% | 1976 |
|
|
2017
Q1 | $4.67M | Buy |
721,100
+568,000
| +371% | +$2.88M | ﹤0.01% | 2443 |
|
|
2016
Q4 | $562K | Buy |
153,100
+4,000
| +3% | +$11.8K | ﹤0.01% | 6736 |
|
|
2016
Q3 | $485K | Sell |
149,100
-14,800
| -9% | -$41.4K | ﹤0.01% | 6109 |
|
|
2016
Q2 | $380K | Sell |
163,900
-132,200
| -45% | -$442K | ﹤0.01% | 6582 |
|
|
2016
Q1 | $740K | Sell |
296,100
-389,400
| -57% | -$876K | ﹤0.01% | 5685 |
|
|
2015
Q4 | $2.1M | Buy |
685,500
+325,600
| +90% | +$909K | ﹤0.01% | 3936 |
|
|
2015
Q3 | $619K | Sell |
359,900
-405,700
| -53% | -$1.04M | ﹤0.01% | 6699 |
|
|
2015
Q2 | $3.11M | Buy |
765,600
+139,500
| +22% | +$570K | ﹤0.01% | 3781 |
|
|
2015
Q1 | $2.4M | Buy |
626,100
+241,000
| +63% | +$1.05M | ﹤0.01% | 3967 |
|
|
2014
Q4 | $1.85M | Sell |
385,100
-78,900
| -17% | -$312K | ﹤0.01% | 4600 |
|
|
2014
Q3 | $1.73M | Buy |
464,000
+74,900
| +19% | +$253K | ﹤0.01% | 4865 |
|
|
2014
Q2 | $1.42M | Sell |
389,100
-144,300
| -27% | -$530K | ﹤0.01% | 5345 |
|
|
2014
Q1 | $2.25M | Sell |
533,400
-356,300
| -40% | -$1.77M | ﹤0.01% | 4140 |
|
|
2013
Q4 | $4.09M | Sell |
889,700
-432,300
| -33% | -$1.92M | ﹤0.01% | 3222 |
|
|
2013
Q3 | $8.18M | Buy |
1,322,000
+641,700
| +94% | +$3.69M | ﹤0.01% | 2116 |
|
|
2013
Q2 | $3.7M | Buy |
+680,300
| New | +$2.23M | ﹤0.01% | 3017 |
|
Susquehanna International Group's IMMU Position: Q4 2020 in Review
Susquehanna International Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 140,618 shares — an estimated $12M sold.
Susquehanna International Group first reported a position in IMMU in Q2 2013 and held it in 27 quarters. The position peaked at $27.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Susquehanna International Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Susquehanna International Group sold 140,618 Immunomedics Inc shares in Q4 2020, an estimated $12M.
- Susquehanna International Group first reported a position in Immunomedics Inc in Q2 2013 and held it in 27 quarters.
- Susquehanna International Group's Immunomedics Inc position peaked at $27.7M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.